Market Research Logo

Global Erectile Dysfunction Market 2016-2020

Global Erectile Dysfunction Market 2016-2020

About Erectile Dysfunction

The loss of erection can be attributed to various factors such as high blood pressure, aging, diabetes mellitus, smoking, alcoholism, depression, nerve or spinal cord damage, and low testosterone levels. The condition can be treated with a broad range of drugs and implants available in the market.

Technavio’s analysts forecast the global erectile dysfunction treatment market to witness a slow grow in market size of USD 4.08 billion during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global erectile dysfunction treatment market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of different types of penile implants, ED creams, and drugs, including branded and generic drugs.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Erectile Dysfunction Treatment Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Bayer
  • Boston Scientific
  • Coloplast
  • Eli Lilly
  • Pfizer
Other prominent vendors
  • Apricus Biosciences
  • Cristalia Produtos Quimicos Farmaceuticos
  • Dong-A Socio
  • Endo Pharmaceuticals
  • Futura Medical
  • Meda Pharmaceuticals
  • Promedon
  • SK Chemical
  • Teva Pharmaceuticals
  • Vivus
  • Zephyr Surgical Implants (ZSI)
Market driver
  • Demand from older adult male population
  • For a full, detailed list, view our report
Market challenge
  • Threat of counterfeit products
  • For a full, detailed list, view our report
Market trend
  • Migration of manufacturing and sales facilities to APAC
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Erectile Dysfunction Treatment Market 2016-2020

Technavio recognizes the following companies as the key players in the global erectile dysfunction treatment market: Bayer, Boston Scientific, Coloplast, Eli Lilly, and Pfizer.

Other Prominent Vendors in the market are: Apricus Biosciences, Cristalia Produtos Quimicos Farmaceuticos, Dong-A Socio, Endo Pharmaceuticals, Futura Medical, Meda Pharmaceuticals, Promedon, SK Chemical, Teva Pharmaceuticals, Vivus, and Zephyr Surgical Implants (ZSI).

Commenting on the report, an analyst from Technavio’s team said: “One of the key drivers for market growth will be migration of manufacturing and sales facilities to APAC. In the recent years many manufacturers of ED products have either established or expanded their current manufacturing and sales network in APAC. This is primarily to capitalize on the high number of ED cases, economy of production offered, and to find easy access to domestic markets at a cheaper logistical cost. The region provides an attractive proposition of low cost of land and material, easily availability of labour, and access to a larger population that will contribute to the growth of the market in the future.”

According to the report, demand from older adult male population will be a key driver for market growth. An increase in sophisticated treatment options and improved standards of healthcare facilities have resulted in an increase in the life expectancy rates leading to a growing older adult population worldwide. With age, the physical, and hormonal changes in the body can cause a decrease in libido, which is a side effect of ED that can occur at any age. ED is more common among older men; seen mostly in men over 40 years of age. The increase in chances of older men getting affected by ED is associated with an unhealthy lifestyle and an increase in stress related activities over the years leading to a decrease in level of libido.

Further, the report states that the main challenge for the market is the patent expiration of major drugs, which will lead to the introduction of a broad range of generic drugs of similar chemical composition for the treatment of ED. These drugs will be available at a much cheaper cost, which can be attributed to limited legal procedures as well as less production expenses related to these generic drugs.

Companies Mentioned

Bayer, Boston Scientific, Coloplast, Eli Lilly, Pfizer, Apricus Biosciences, Cristalia Produtos Quimicos Farmaceuticos, Dong-A Socio, Endo Pharmaceuticals, Futura Medical, Meda Pharmaceuticals, Promedon, SK Chemical, Teva Pharmaceuticals, Vivus, and Zephyr Surgical Implants (ZSI).

  • Executive summary
    • Highlights
  • Scope of the report
    • Market overview
      • Definition
        • Table Global erectile dysfunction treatment market by product
        • Table Key countries
    • Vendor segmentation
    • Top-vendor offerings
      • Table Product offerings
  • Market research methodology
    • Research methodology
    • Economic indicators
  • Introduction
    • Key market highlights
  • Market landscape
    • Market overview
      • Table Major causes of ED
    • Market size and forecast
      • Table Global ED treatment market 2015-2020 ($ billions)
      • Table Key drug patent expirations in major countries
    • Five forces analysis
      • Table Five forces analysis
  • Market segmentation by product
    • Global ED treatment market by product
      • Table Global ED treatment market by product 2015 and 2020
      • Table Global ED treatment market by product 2015-2020
    • Global ED drugs market
      • Table Global ED drugs market 2015-2020 ($ billions)
    • Global ED devices market
      • Table Global ED devices market 2015-2020 ($ millions)
      • Table ED device market by geography 2015 and 2020
  • Market segmentation by type of ED drugs
    • Global ED treatment market by type of ED drugs
      • Table Global ED treatment market by type of ED drugs 2015
  • Market segmentation by type of ED device
    • Global ED treatment market by type of ED device
      • Table Global ED treatment market by type of ED device 2015 and 2020
  • Geographical segmentation
    • Global ED treatment market by geography
      • Table Global ED treatment market by geography 2015 and 2020
      • Table Global ED treatment market by geography 2015-2020 ($ millions)
    • ED treatment market in Americas
      • Table ED treatment market in Americas 2015-2020 ($ billions)
      • Table ED treatment market in Americas by drugs and devices
    • ED treatment market in EMEA
      • Table ED treatment market in EMEA 2015-2020 ($ billions)
      • Table Occurrence of ED by age 2015
      • Table ED treatment market in EMEA by drugs and devices 2015 and 2020
    • ED treatment market in APAC
      • Table ED treatment market in APAC 2015-2020 ($ millions)
      • Table ED treatment market in APAC by drugs and devices 2015 and 2020
      • Table ED treatment Market by product across regions 2015 and 2020 ($ million)
  • Market drivers
    • Table Estimated cancer cases and deaths in US 2016 (thousands)
    • Table Chances of men developing ED by age in the US
    • Table Number of individuals with diabetes around the world 2015 and 2040 (millions)
  • Impact of drivers
    • Table Impact of drivers
  • Market challenges
  • Impact of drivers and challenges
    • Table Impact of drivers and challenges
  • Market trends
  • Vendor landscape
    • Competitive scenario
  • Key vendor analysis
    • Bayer
      • Table Bayer: Key takeaways
    • Boston Scientific
      • Table Boston Scientific: Key takeaways
    • Coloplast
      • Table Coloplast: Key takeaways
    • Eli Lilly
      • Table Eli Lilly: Key takeaways
    • Pfizer
      • Table Pfizer: Key takeaways
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report